KARYOPHARM THERAPEUTICS INC

CUSIP: 48576U106 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 76,317 Value ($000) $115 Avg Close Range
Q4 2023
Shares 71,224 Value ($000) $62 Avg Close Range
Q3 2023
Shares 35,279 Value ($000) $47 Avg Close Range
Q2 2023
Shares 37,490 Value ($000) $67 Avg Close Range
Q1 2023
Shares 187,450 Value ($000) $729 Avg Close Range
Q4 2022
Shares 432,278 Value ($000) $1,470 Avg Close Range
Q3 2022
Shares 155,433 Value ($000) $849 Avg Close Range
Q2 2022
Shares 45,978 Value ($000) $207 Avg Close Range
Q2 2019
Shares 57,681 Value ($000) $346 Avg Close Range
Q1 2019
Shares 130,956 Value ($000) $765 Avg Close Range
Q1 2016
Shares 27,300 Value ($000) $244 Avg Close Range
Q4 2015
Shares 41,100 Value ($000) $545 Avg Close Range
Q3 2015
Shares 40,075 Value ($000) $422 Avg Close Range
Q2 2015
Shares 45,700 Value ($000) $1,243 Avg Close Range
Q1 2015
Shares 44,100 Value ($000) $1,350 Avg Close Range
Q4 2014
Shares 11,000 Value ($000) $412 Avg Close Range